http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899075

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
endingPage 1802
issn 0007-0920
1532-1827
issueIdentifier 12
pageRange 1797-1802
publicationName British Journal of Cancer
startingPage 1797
bibliographicCitation López-Pousa A, Losa R, Martín J, Maurel J, Fra J, Sierra M, Casado A, García del Muro J, Poveda A, Balañá C, Martínez-Trufero J, Esteban E, Buesa JM. Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. British Journal of Cancer. 2006 May 23;94(12):1797–802. doi: 10.1038/sj.bjc.6603187.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db2edde3161e0d57f00bcba77d2b64b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fffd35256d16ec7fce31da423e1fdebd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7918628952184368dd1efa08da0bcdd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88f867f815356e28bf6656597dc52bb0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6116f1d99e32fd179292a41d2512e959
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c6c21fa8c0a795174f64f6ca440269f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d79d46e5d24db69e4450a75fc204074d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0399cc401d5baba2c6591a727d80744
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3d6b3217bb3f6a73aa0bec3678c825b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f95348f5db75ee0f31e85d42d105f59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef7d6d4acfe7a86899fd68468ab09d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_306e05bad0b928a771fd3d8f68fd7965
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f896f864396cf5c091e4f5bf535164ed
date 2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6603187
https://pubmed.ncbi.nlm.nih.gov/16721358
https://pubmed.ncbi.nlm.nih.gov/PMC2361345
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
discusses http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M000754277
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871558
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6830
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130659
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129348475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127852931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 62.